Other
Ankle Brachial Index
Total Trials
4
Max Phase
—
Type
OTHER
Molecule
—
Success Metrics
Completion Rate
0%(0/2)
Active Trials
0(0%)
Terminated
2(50%)
Phase Distribution
Ph not_applicable
1
25%
Ph phase_4
1
25%
Phase Distribution
0
Early Stage
0
Mid Stage
1
Late Stage
Phase Distribution2 total trials
Phase 4Post-market surveillance
1(50.0%)
N/ANon-phased studies
1(50.0%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
0.0%
0 of 2 finished
Non-Completion Rate
100.0%
2 ended early
Currently Active
0
trials recruiting
Total Trials
4
all time
Status Distribution
Active(1)
Terminated(2)
Other(1)
Detailed Status
Terminated2
Not yet recruiting1
unknown1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
0
Success Rate
0.0%
Most Advanced
Phase 4
Trials by Phase
Phase 41 (50.0%)
N/A1 (50.0%)
Trials by Status
terminated250%
not_yet_recruiting125%
unknown125%
Recent Activity
0 active trials
Showing 4 of 4
not_yet_recruiting
Predictors of Diabetic Foot Outcome in Chronic Kidney Disease Patients
NCT06684886
terminated
Biofilm Modified Macrophage Phenotype and Function in Diabetic Wound Healing
NCT03271580
unknownnot_applicable
Tissue Changes in Diabetes in Adults and Children Using Multispectral Optoacoustic Tomography.
NCT05935839
terminatedphase_4
Ticagrelor and Peripheral Arterial Disease
NCT02407314
Clinical Trials (4)
Showing 4 of 4 trials
NCT06684886
Predictors of Diabetic Foot Outcome in Chronic Kidney Disease Patients
NCT03271580
Biofilm Modified Macrophage Phenotype and Function in Diabetic Wound Healing
NCT05935839Not Applicable
Tissue Changes in Diabetes in Adults and Children Using Multispectral Optoacoustic Tomography.
NCT02407314Phase 4
Ticagrelor and Peripheral Arterial Disease
All 4 trials loaded
Drug Details
- Intervention Type
- OTHER
- Total Trials
- 4